By Dr. Kirk Sanford, DC · Founder, Longevity Medical Institute
One of the most common misconceptions in this field is that a stem cell is a stem cell. In practice, where a cell comes from meaningfully changes how it behaves — and a clinic that uses only one source is limited to whatever that source happens to do well.
Because stem cells are central to what we do, you deserve to understand them more deeply than a single passing mention. This is one of the places where the differences between providers are real and important — and where being an informed patient protects you. Start with a common misconception. Many people assume all stem cells are essentially the same — that “stem cell therapy” means one kind of cell, obtained more or less interchangeably. The reality is more nuanced. While mesenchymal stem cells share certain defining features, their biological behavior can vary depending on the tissue they come from. Differences in growth, signaling, and secretome composition all influence how a given preparation interacts with the body. IN PLAIN TERMS If you were staffing a construction crew, you would care where your workers trained. A foreman from a busy commercial site brings different instincts than one who built quiet country homes. Cells drawn from different tissues are much the same — they carry different strengths, shaped by the environment they came from. At our institute, we work with five distinct mesenchymal stem cell preparations rather than treating all cells as interchangeable. You do not need to memorize them, but understanding what each brings is part of understanding why a thoughtful approach matters. Here they are, in plain terms. Placental cells (from the placenta). The placenta is a remarkable temporary organ built during pregnancy to support rapid growth, build blood supply, and manage immune interactions between mother and baby. Cells drawn from it tend to be highly active biological communicators — strong at producing growth factors, calming inflammation, and stimulating new blood vessels. Because they come from young, developmentally fresh tissue that has not weathered decades of stress, they are among the most studied and widely used in regenerative research. Wharton's Jelly cells (from the umbilical cord). Wharton's Jelly is the soft, protective tissue surrounding the vessels inside the umbilical cord — one of the youngest tissues available in nature. Cells from it are known for vigorous growth, strong secretion of signaling molecules, low likelihood of provoking an immune reaction, and especially rich exosome production. Their developmental youth is thought to contribute to how biologically active they are. Adipose cells (from body fat). Fat is far more than storage; it is an active, signaling tissue, and it is an abundant and accessible source of stem cells in the adult body. Adipose-derived cells are valued for strong growth, robust blood-vessel signaling, immune- calming effects, and extensive vesicle production — with the practical advantage that the source tissue is relatively easy to obtain. Endometrial cells (from the uterine lining). The endometrium is one of the few tissues in the body that naturally regenerates itself over and over throughout life, rebuilding extensively each month. Cells from this remarkably regenerative tissue show strong growth, notable blood-vessel and tissue-remodeling activity, and high regenerative signaling — which makes them a particularly intriguing area of study for tissue repair and longevity. Dental pulp cells (from the soft center of a tooth). Dental pulp cells are distinctive because of their developmental origin: many arise from neural crest tissue, the embryonic structure that helps form parts of the nervous system. Because of this heritage, they are of special interest for nerve-related signaling and repair, and they are reported to be strong producers of neurotrophic (nerve-supporting) factors, as well as active in exosome production and immune modulation. Notice the pattern across all five. Each comes from a tissue with a particular biological talent — the placenta's growth activity, the cord's developmental youth, fat's accessibility and signaling, the endometrium's natural regeneration, the tooth's neural heritage — and each tends to carry the strengths of its origin. Matching the characteristics of a preparation to its purpose is part of doing this work thoughtfully. But here is the crucial balance, and it echoes the central message of this book: these five are more alike than different. All of them self-renew, all release signaling molecules and exosomes, all interact with the immune system, and all work primarily through communication rather than replacement. The goal is not to crown one “best” cell, but to understand how different origins contribute different strengths within the same underlying mechanism. And ultimately, what matters most is not where a cell came from, but what it releases — the secretome, which is where we turn next. As a patient, you do not need to become a cell biologist. But you can ask a simple, revealing question: what cells do you use, where do they come from, and why these? A provider who can answer thoughtfully is a provider taking the science seriously.
Yes. Cells from different tissues have different signaling profiles and different strengths.
No. Matching the cell type to the problem is part of what makes a protocol legitimate rather than generic.
This chapter is part of The Language of Healing: A Patient's Introduction — a free, plain-language guide to regenerative medicine.
One hundred percent of the proceeds from the Complete Patient Guide support regenerative care for active-duty military and veterans.